US Bancorp DE Trims Holdings in Colgate-Palmolive Company $CL

US Bancorp DE cut its holdings in Colgate-Palmolive Company (NYSE:CL) by 4.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 322,606 shares of the company’s stock after selling 14,187 shares during the quarter. US Bancorp DE’s holdings in Colgate-Palmolive were worth $25,492,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CL. Brighton Jones LLC grew its position in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after buying an additional 450 shares during the period. Woodline Partners LP grew its position in shares of Colgate-Palmolive by 76.3% in the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after buying an additional 20,062 shares during the period. Schnieders Capital Management LLC. grew its position in shares of Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after buying an additional 245 shares during the period. Nebula Research & Development LLC grew its position in shares of Colgate-Palmolive by 165.5% in the 2nd quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock worth $939,000 after buying an additional 6,437 shares during the period. Finally, Sei Investments Co. grew its position in shares of Colgate-Palmolive by 21.7% in the 2nd quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock worth $59,732,000 after buying an additional 116,968 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently commented on CL shares. Jefferies Financial Group increased their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Citigroup increased their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Bank of America cut their price objective on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research report on Friday, April 10th. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. Finally, Barclays cut their price objective on shares of Colgate-Palmolive from $88.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 14th. Twelve investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $95.56.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $87.15 on Friday. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company’s 50-day moving average is $87.95 and its 200 day moving average is $84.06. The company has a market capitalization of $69.92 billion, a price-to-earnings ratio of 33.26, a price-to-earnings-growth ratio of 4.37 and a beta of 0.31. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.91 EPS. Sell-side analysts expect that Colgate-Palmolive Company will post 3.85 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 80.92%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the transaction, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Panagiotis Tsourapas sold 35,000 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the transaction, the chief operating officer owned 10,415 shares in the company, valued at $985,363.15. This represents a 77.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 184,683 shares of company stock worth $17,486,693 over the last quarter. 0.43% of the stock is currently owned by insiders.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Q1 top‑ and bottom‑line beat — Colgate reported EPS of $0.97 vs. $0.95 consensus and revenue of $5.32B (up 8.4% YoY), driven by pricing and volume growth; organic sales rose and base business EPS increased. Colgate Q1 Earnings & Sales Beat Estimates on Pricing & Volume Growth
• Positive Sentiment: Strong international demand for core oral and personal care boosted results and topline momentum, a cited driver behind the beat. Colgate‑Palmolive beats Q1 estimates on strong international demand
• Positive Sentiment: Board expands strategic growth & restructuring program — management is accelerating a multi‑year program (approved July 2025) intended to drive growth and cost savings, which supports margin recovery expectations. Colgate‑Palmolive Expands Strategic Growth and Restructuring Program
• Neutral Sentiment: Management commentary and slides — the earnings call and slide deck provide detail on region‑level trends, pricing versus volume dynamics, and the timing of savings from the restructuring program. Review the transcript/slides for forward commentary. Colgate‑Palmolive Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Analysts updated forecasts ahead of and after the print — some revisions were already in place heading into the quarter; keep an eye on any further changes to price targets or model assumptions. Colgate‑Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
• Negative Sentiment: Margin pressure and one‑time/SGPP charges — GAAP EPS fell YoY (to $0.80) and gross profit margin slipped ~20 bps; management flagged costs and restructuring/SGPP charges that weighed on margins this quarter. These items are a watch point for near‑term profitability until savings materialize. Colgate Announces 1st Quarter 2026 Results

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.